CytoVas, LLC is an early-stage, in-vitro diagnostics (IVD) company developing advanced cell- and particle-based assays for evaluating the health of the cardiovascular system. Our products leverage the power of cytomics and a unique computation analysis approach to deliver a comprehensive picture of the patient’s vascular health status. Our technology addresses a broad range of applications, including: drug development, clinical trial design, monitoring cardiovascular responses to drug therapy (personalized medicine), companion diagnostics (theranostics), and clinical diagnostics.
Sign up for news and updates:
Contact Form